Provided by Tiger Trade Technology Pte. Ltd.

Immunocore Holdings plc

35.98
-0.0300-0.08%
Post-market: 35.980.00000.00%16:10 EST
Volume:465.68K
Turnover:16.89M
Market Cap:1.82B
PE:-61.82
High:37.17
Open:35.83
Low:35.41
Close:36.01
52wk High:40.71
52wk Low:23.15
Shares:50.53M
Float Shares:37.57M
Volume Ratio:2.11
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5821
EPS(LYR):-1.0219
ROE:-7.55%
ROA:-1.55%
PB:4.58
PE(LYR):-35.21

Loading ...

Immunocore Head of R&D David M. Berman Reports Disposal of Common Shares

Reuters
·
Dec 09

Immunocore Head of R&D David M. Berman Reports Disposal of Common Shares

Reuters
·
Dec 02

Immunocore Holdings Board Member Ranjeev Krishana Resigns

TIPRANKS
·
Nov 28

Immunocore Holdings Announces Board and HR Chief Resignations

Reuters
·
Nov 28

Immunocore Head of R&D David M. Berman Reports Disposal of Common Shares

Reuters
·
Nov 27

H.C. Wainwright Reaffirms Their Buy Rating on Immunocore Holdings (IMCR)

TIPRANKS
·
Nov 22

A Fresh Look at Immunocore Holdings (NasdaqGS:IMCR) Valuation After Positive Phase 1 Data for HBV Therapy

Simply Wall St.
·
Nov 19

Immunocore Holdings Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Nov 11

Immunocore price target raised to $36 from $34 at Morgan Stanley

TIPRANKS
·
Nov 11

Stock Track | Immunocore Holdings Soars 5% as Investors Anticipate Guggenheim Conference Presentation

Stock Track
·
Nov 11

Immunocore Holdings to Present at Guggenheim Healthcare Innovation Conference

Reuters
·
Nov 10

Immunocore Holdings (IMCR) Gets a Hold from Mizuho Securities

TIPRANKS
·
Nov 10

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Immunocore Holdings (IMCR)

TIPRANKS
·
Nov 09

Stock Track | Immunocore Holdings Soars 5.21% on Promising Phase 1 Results for Hepatitis B Drug

Stock Track
·
Nov 08

Stock Track | Immunocore Soars 5.21% on Promising Phase 1 Results for Hepatitis B Drug Candidate

Stock Track
·
Nov 08

Immunocore Says Hep B Drug Trial Shows Encouraging Data

Dow Jones
·
Nov 07

Immunocore Reports Promising Phase 1 Results for HBV Candidate IMC-I109V

Reuters
·
Nov 07

Immunocore Holdings (IMCR) Receives a Buy from Needham

TIPRANKS
·
Nov 06

Immunocore Hldgs Q3 Sales $103.693M Beat $100.186M Estimate

Benzinga
·
Nov 06

Immunocore - Qtrly Diluted Net Loss per Share Was $0.00

THOMSON REUTERS
·
Nov 06